Anne Hege A.
- Country
- Norway
- Department
- Neurology
Research Overview
- A multicentre, triple blind, placebo controlled, parallel group study of atorvastatin in chronic migraine
- Efficacy of Intravenous Tocilizumab on Infarct Growth in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: A Phase II Randomized Controlled Trial
- Evaluation of Tenecteplase Versus Acetylsalicylic Acid in Central Retinal Artery Occlusion: A Phase 3 Randomized, Double-Blind, Double-Dummy Trial
Data & Insights
Has run more than one trial at 13 of 26 partner sites.
Specializations
Neurovascular Disorders
This investigator specializes in treating central retinal artery occlusion, focusing on innovative therapeutic approaches for acute vision loss. Their research explores time-sensitive interventions using thrombolytic agents for retinal vessel blockages.
- Acute vision loss management
- Retinal vascular disorders
- Emergency ophthalmology interventions
Headache Medicine
The investigator demonstrates particular expertise in migraine disorders, with a focus on both episodic and chronic presentations. Their work explores innovative therapeutic approaches using lipid-lowering medications for migraine prevention.
- Chronic migraine management
- Episodic migraine treatment
- Preventative therapy development
Therapeutic Innovation
The investigator's work encompasses novel applications of established medications for neurological conditions. Their research explores alternative uses of cardiovascular medicines in neurological disorders.
- Drug repurposing strategies
- Preventative therapeutics
- Multi-center clinical research
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.